Risk factors associated with COVID-19 patients in the Northern part of Bangladesh

M. Abu Zahid, M. Bashir Uddin, Mazharul Islam


Background: In several countries, health care delivery is being compromised due to the surge in the number of infected patients during the pandemic.

Methods: This was a retrospective COHORT study which was conducted at the department of cardiology at Rangpur medical college hospital, Rangpur, Bangladesh during the period from July 2020 to December 2020. In total, 235 laboratory-confirmed COVID-19 cases were included in the study population. Proper written consent was obtained from the participants before data collection. A pre-designed questionnaire was used in the patent data collection. All data was processed, analyzed and compiled using Microsoft office and statistical package for the social sciences (SPSS) version 22.

Results: In this study, in analyzing the risk factors of COVID-19, 10 factors were found to be considerable, which were gender as male, age of ≥65 years, smoking, two or more comorbidities, diabetes mellitus, hypertension, chronic respiratory disease (CRD), chronic kidney diseases, cardiac diseases and cancer/immunodeficiency. But finally, gender as male, age of ≥65 years, two or more comorbidities at a time, CRD and cardiac diseases were found as the most potential risk factors for COVID-19 and against those risk factors the p values were found to be 0.023, 0.003, 0.004, 0.005 and 0.032 respectively.

Conclusions: In this study, gender was defined as male, age of ≥65 years, two or more comorbidities at a time and CRD and cardiac diseases were found as the most potential risk factors for COVID-19. To get more reliable information, we would like to recommend conducting more studies in several places with larger samples.


Risk factors, COVID-19, CRD, Corona, Clinical status

Full Text:



NHS England. COVID-19 daily deaths. Available at: https://www. england. statistics/statistical-work-areas/covid-19-daily-deaths/. Accessed on 05 January 2022.

Deng G, Yin M, Chen X, Zeng F. Clinical determinants for fatality of 44,672 patients with COVID-19. Crit Care. 2020;24:179.

Docherty AB, Harrison EM, Green CA, Hardwick H, Pius R, Norman L, et al. Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO clinical characterisation protocol. MedRxiv. 2020.

Simonnet A, Chetboun M, Poissy J, Raverdy V, Noulette J, Duhamel A, et al. High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity (Silver Spring). 2020;28(7):1195-9.

Lighter J, Phillips M, Hochman S, Sterling S, Johnson D, Francois F, Stachel A. Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital Admission. Clin Infect Dis. 2020;71(15):896-7.

Simons D, Shahab L, Brown J, Perski O. The association of smoking status with SARS-CoV-2 infection, hospitalization and mortality from COVID-19: a living rapid evidence review with Bayesian meta-analyses (version 7). Addiction. 2021;116(6):1319-68.

Khunti K, Singh AK, Pareek M, Hanif W. Is ethnicity linked to incidence or outcomes of covid-19? Br Med J. 2020;369:1548.

Directorate General of Health Services (DGHS). National Guidelines on Clinical Management of Coronavirus Disease 2019 (COVID-19), Bangladesh (version 7.0). 2020. Available at: https://covidlaw 2020.11.05_Guideline_National-Guidelines-on-Clinical-Management-of-COVID-19_EN.pdf. Accessed on 05 January 2022.

Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. J Autoimmun. 2020;109:102433.

Zhang JJ, Dong X, Cao YY, Yuan YD, Yang YB, Yan YQ, Akdis CA, Gao YD. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730-41.

Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62.

Guan WJ, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708-20.

Alsofayan Y, Althunayyan S, Khan A, Hakawi A, Assiri A. Clinical characteristic of COVID-19 in Saudi Arabia: A national retrospective study. J Infect Public Health. 2020;13(7):920-5.

World Health Organization. National laboratories. 2020. Available at: emergencies/ diseases/ novel- coronavirus-2019/technical-guidance/laboratory-guidance/. Accessed on 08 June 2020.

World Health Organization. ICD-10 for Mortality and Morbidity Statistics. 2019. Available at: Accessed on 24 May 2020.

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of coronavirus disease 2019 in China. New Engl J Med. 2020;382(18):1708-20.

COVID-19 coronavirus disease guidelines. Riyadh: Ministry of Health. 2020. Available at: Publications/Documents/Coronavirus-Disease-2019-Guidelines-v1.2.pdf. Accessed on 28 May 2020.

Chen T, Wu D, Chen H, Yan W, Yang D, Chen G, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020;180(7):934-43.

Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA. 2020;323(16):1574-81.

Khoja AT, Aljawadi MH, Al-Shammari SA, Mohamed AG, Al-Manaa HA, Morlock L, et al. The health of Saudi older adults; results from the Saudi National Survey for elderly health (SNSEH) 2006–2015. Saudi Pharm J. 2018;26(2):292-300.

Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO clinical characterization protocol: prospective observational cohort study. BMJ. 2020;369:m1985.

Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;531-8.

Shi S, Qin M, Shen B, Cai Y, Liu T, Yang F, et al. Association of cardiac injury with mortality in hospitalized patients with COV- ID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802-10.